SEATTLE VACCINE RESEARCH FUND (EIN 331111221) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Phone

2066672092

Tax Period

2023-07-01 to 2024-06-30

SEATTLE VACCINE RESEARCH FUND, founded in 2004, is a small nonprofit in the Diseases & Disorders sector that reported $131K in total revenue in fiscal year 2023. Revenue surged 47% from the prior year, signaling strong growth momentum.

Mission

PROVIDING ANTI-RETROVIRALS TO ELIGIBLE HIV VACCINE TRIALS NETWORK PARTICIPANTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $130,846

Other Revenue $0

TOTAL REVENUE $130,846

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $0

Other Expenses $0

TOTAL EXPENSES $0

Year-over-Year Comparison

	2023	2022	Change
Revenue	$130,846	$89,150	+0.5%
Expenses	N/A	$2,999	-1.0%
Net Income	N/A	$86,151	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,446,430

Total Directors

$1,446,430

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Larry Corey MD	President	1.00	Officer Director	$0	$72,691	$437,841
James Kublin MD MP	Vice-President	1.00	Officer Director	$0	$66,469	$453,696
Bryon Epp	Secretary and Treasurer - Beg 5-8-24	1.00	Officer Director	$0	$50,380	$215,695
Christopher Bundesmann	Secretary and Treasurer - Until 5-8-24	1.00	Officer Director	$0	$50,244	$339,198
Scott Wilson	Director	1.00	Director	$0	$0	$0
Cindy Zehnder	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$130,846	No data	$2,754,721	No data
2023	$89,150	$2,999	$2,623,875	$86,151
2022	$5,507	$224,982	$2,537,724	$-219,475

SEATTLE VACCINE RESEARCH FUND